Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,376,819 papers from all fields of science
Search
Sign In
Create Free Account
Alopecia
Known as:
Hair Loss
, Alopecia, unspecified
, Alopecia [Disease/Finding]
Expand
Hair loss usually from the scalp. It may result in bald spots or spread to the entire scalp or the entire epidermis. It may be androgenetic or caused…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
48 relations
Narrower (25)
Alopecia epilepsy oligophrenia syndrome of Moynahan
Alopecia universalis
Alopecia, Androgenetic, 3
Alopecia, Familial Focal
Expand
Atrichia
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT
Dermatologic disorders
Fibrodysplasia Ossificans Progressiva
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Assessing benefit transfer for the valuation of ecosystem services
M. Plummer
2009
Corpus ID: 84931250
The valuation of ecosystem services can play an important role in conservation planning and ecosystem-based management…
Expand
Review
2008
Review
2008
Chemotherapy‐induced alopecia and effects on quality of life among women with breast cancer: a literature review
J. Lemieux
,
E. Maunsell
,
L. Provencher
Psycho-Oncology
2008
Corpus ID: 511697
Background: Alopecia is a common side effect of chemotherapies used in the treatment of breast cancer. The aim of this review is…
Expand
Review
2005
Review
2005
The psychological impact of alopecia
N. Hunt
,
S. McHale
British medical journal
2005
Corpus ID: 20854054
Alopecia is a chronic dermatological disorder in which people lose some or all of the hair on their head and sometimes on their…
Expand
Highly Cited
2002
Highly Cited
2002
A 90-day oral gavage toxicity study of D-methylphenidate and D,L-methylphenidate in Sprague-Dawley rats.
S. Teo
,
D. Stirling
,
S. Thomas
,
A. Hoberman
,
A. Kiorpes
,
V. Khetani
Toxicology
2002
Corpus ID: 20060555
Highly Cited
1998
Highly Cited
1998
The greatest benefit to mankind : a medical history of humanity
R. Porter
1998
Corpus ID: 70523884
THE GREATEST BENEFIT TO MANKIND A MEDICAL HISTORY OF HUMANITY ROY PORTER PDF Are you looking for THE GREATEST BENEFIT TO MANKIND…
Expand
Highly Cited
1997
Highly Cited
1997
Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer.
A. Gramont
,
J. Vignoud
,
+7 authors
M. Krulik
European Journal of Cancer
1997
Corpus ID: 24416232
Highly Cited
1996
Highly Cited
1996
Damage to hair follicles by normal-mode ruby laser pulses.
M. Grossman
,
C. Dierickx
,
W. Farinelli
,
T. Flotte
,
R. Anderson
Journal of American Academy of Dermatology
1996
Corpus ID: 9897917
Highly Cited
1992
Highly Cited
1992
A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy…
R. Mattson
,
J. Cramer
,
J. Collins
New England Journal of Medicine
1992
Corpus ID: 37374216
BACKGROUND Valproate is approved for use primarily in patients with absence seizures, but the drug has a broad spectrum of…
Expand
Highly Cited
1991
Highly Cited
1991
Estimated lifetime prevalence of trichotillomania in college students.
G. Christenson
,
R. Pyle
,
J. Mitchell
Journal of Clinical Psychiatry
1991
Corpus ID: 8160896
BACKGROUND Trichotillomania, a disorder of hair pulling, has been considered a rare condition. Estimations of the prevalence of…
Expand
Highly Cited
1959
Highly Cited
1959
AUTOGRAFTS IN ALOPECIAS AND OTHER SELECTED DERMATOLOGICAL CONDITIONS
N. Orentreich
Annals of the New York Academy of Sciences
1959
Corpus ID: 35356631
pigment formation,1-2 s5-' wound healing,lO-ll and immunity.12 Exchange autografts were performed in man to study ~itiligo…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE